WILMINGTON, Del., April 13, 2016 -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Apigee Corporation (NASDAQ:APIC)?
- Did you purchase your shares pursuant and/or traceable to the initial public offering on or about April 24, 2015?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. announces that a complaint has been filed in the Superior Court of the State of California, County of San Mateo, on behalf of all persons or entities that purchased the common stock of Apigee Corporation (“Apigee” or the “Company”) (NASDAQ:APIC) pursuant or traceable to its initial public offering (“IPO”) commenced on or about April 24, 2015, alleging violations of the Securities Exchange Act of 1933 against the Company, the sponsors of the IPO, and certain of the Company’s officers (the “Complaint”).
If you purchased shares of Apigee in connection with its IPO, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/apigee-corporation-apic.
The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. As a result of defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.
According to the Complaint, the documents filed in connection with the IPO contained materially false and misleading statements and/or failed to disclose that: (1) Apigee faced direct competition from Amazon, upon whose platform Apigee’s entire cloud infrastructure was running, and who was preparing to compete against Apigee for potential new customers, particularly potential new customers who were already using Amazon’s new technology stack; (2) Apigee’s 2Q 2015 revenues of just $17 million had included an “unusually large transaction” of $5.9 million from just one customer which had comprised approximately 35% of that quarter’s revenues and was not repeating going forward; (3) Apigee’s 4Q 2014 billings of just $21.7 million had included $8.6 million from three very large deal that had comprised a full 39% of that quarter’s revenues and were not repeating going forward; (4) lowered demand for Apigee’s product offerings was requiring the Company to scale back on its direct sales efforts and to focus more of its efforts on selling through channel partners such as Accenture and SAP; (5) as a result of the foregoing, Apigee was experiencing lowered billings; and (6) as a result, at the time of the IPO, the Company’s business and financial prospects were not what defendants had led the market to believe they were in the Registration Statement.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



